Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Iterum Therapeutics plc revenue
Iterum Therapeutics plc's revenue is $1.0 million.
What is Iterum Therapeutics plc's revenue?
- Iterum Therapeutics plc has 48 employees, and the revenue per employee ratio is $20,833.
- Iterum Therapeutics plc peak revenue was $1.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Iterum Therapeutics plc financing
Iterum Therapeutics plc received early financing of $40.0M on 2016-03-24.
| Series | Round size | Date |
|---|---|---|
| Series A | $40M | 03/2016 |
| Series B | $65M | 05/2017 |
| Grant | $1.5M | 07/2017 |
| Post Ipo Equity | $51.9M | 01/2020 |
| Post Ipo Equity | $10M | 02/2021 |
| Post Ipo Equity | $35M | 02/2021 |
Iterum Therapeutics plc investors
| Investors | Security type |
|---|---|
| Canaan | Series A |
| Frazier Healthcare Partners | Series A |
| SOFINNOVA INVESTMENTS INC | Series A |
| New Leaf Venture Partners | Series A |
| Bay City Capital | Series B |
| ARIX BIOSCIENCE PLC | Series B |
| Canaan | Series B |
| Frazier Healthcare Partners | Series B |
| SOFINNOVA INVESTMENTS INC | Series B |
| Advent Life Sciences LLP | Series B |
| Domain Associates | Series B |
| PIVOTAL BIOVENTURE PARTNERS | Series B |
| New Leaf Venture Partners | Series B |
| CARB-X | Grant |
| Sarissa Capital Management | Post Ipo Equity |
| RA Capital Management | Post Ipo Equity |
Iterum Therapeutics plc revenue FAQs
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Iterum Therapeutics plc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Iterum Therapeutics plc. The employee data is based on information from people who have self-reported their past or current employments at Iterum Therapeutics plc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Iterum Therapeutics plc. The data presented on this page does not represent the view of Iterum Therapeutics plc and its employees or that of Zippia.
Iterum Therapeutics plc may also be known as or be related to ITERUM THERAPEUTICS PLC, Iterum Therapeutics, Iterum Therapeutics Ltd, Iterum Therapeutics Ltd. and Iterum Therapeutics plc.